Log In
Print
BCIQ
Print
Print this Print this
 

Epzicom, Kivexa (abacavir/lamivudine)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOral fixed-dose combination of nucleoside reverse transcriptase inhibitors (NRTIs) lamivudine and abacavir
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection/AIDS; Treat HIV infection/AIDS in antiretroviral-naïve patients; Treat HIV-1 infection
Regulatory Designation

Partner

ViiV Healthcare Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today